1 |
de Barros C, Portugal I, Batain F, Portella D, Severino P, Cardoso J, Arcuri P, Chaud M, Alves T. Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems. RPS Pharmacy and Pharmacology Reports 2022;1. [DOI: 10.1093/rpsppr/rqac003] [Reference Citation Analysis]
|
2 |
Celichowska M, Miedziaszczyk M, Lacka K. Pharmacotherapy in Cachexia: A Review of Endocrine Abnormalities and Steroid Pharmacotherapy. J Pain Palliat Care Pharmacother 2022;36:117-31. [PMID: 35758863 DOI: 10.1080/15360288.2022.2063469] [Reference Citation Analysis]
|
3 |
Sabir F, Ain QU, Rahdar A, Yang Z, Barani M, Bilal M, Bhalla N. Functionalized Nanoparticles in Drug Delivery: Strategies to Enhance Direct Nose-to-Brain Drug Delivery via Integrated Nerve Pathways. Synthesis and Applications of Nanoparticles 2022. [DOI: 10.1007/978-981-16-6819-7_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Das B, Basu A, Hasnain MS, Nayak AK. Liposomes as efficient lipid nanovesicular systems for drug delivery. Systems of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91864-0.00024-3] [Reference Citation Analysis]
|
5 |
Barros C, Aranha N, Severino P, Souto EB, Zielińska A, Lopes A, Rios A, Batain F, Crescencio K, Chaud M, Alves T. Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration. Pharmaceutics 2021;13:686. [PMID: 34068793 DOI: 10.3390/pharmaceutics13050686] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|